Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan

Sodium-glucose cotransporter-2 inhibitors (SGLT2I) have been reported to have renal-protective effects in patients with type 2 diabetes (T2DM). This a retrospective study aimed to evaluate the effect of SGLT2I on renal function in patients with nonalcoholic fatty liver disease (NAFLD) and T2DM. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yano, Kota, Seko, Yuya, Takahashi, Aya, Okishio, Shinya, Kataoka, Seita, Takemura, Masashi, Okuda, Keiichiroh, Mizuno, Naoki, Taketani, Hiroyoshi, Umemura, Atsushi, Nishikawa, Taichiro, Yamaguchi, Kanji, Moriguchi, Michihisa, Okanoue, Takeshi, Itoh, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168325/
https://www.ncbi.nlm.nih.gov/pubmed/32041289
http://dx.doi.org/10.3390/diagnostics10020086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168325/
https://www.ncbi.nlm.nih.gov/pubmed/32041289
http://dx.doi.org/10.3390/diagnostics10020086

Ejemplares similares